Doseology closes acquisition of Feed That Brain unit

Executive Summary

• Doseology Sciences Inc. has officially closed the acquisition of the "Feed That Brain" division from Joseph Mimran & Associates Inc.
• The transaction was settled via the issuance of 175,000 common shares to the vendor, representing the first payment under the asset purchase agreement.
• The acquired shares are subject to a standard four-month hold period under Canadian securities laws.

Key Details

• Transaction Status: Closed acquisition of the Feed That Brain division.
• Vendor: Joseph Mimran & Associates Inc.
• Consideration: Issuance of 175,000 common shares of Doseology Sciences Inc.
• Valuation: Deemed price of $1.00 per share.
• Total Value of First Payment: $175,000.
• Regulatory Conditions: Shares issued are subject to a four-month hold period in accordance with Canadian securities laws.
• Context: This release serves as a confirmation of the closing following the initial announcement on August 19, 2025.

Notable Quotes

• None provided in the text.